- Aspenberg P. Bisphosphonates and fatigue fractures. IBMS BoneKEy 2009; 6:465-9.
- Black DM, Schwartz AV, Ensrud KE, Cauley JA, Levis S, Quandt SA, Satterfield S, Wallace RB, Bauer DC, Palermo L, Wehren LE, Lombardi A, Santora AC, Cummings SR, FLEX Research Group. Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial. JAMA. 2006; 296:2927-38.
- Black DM, Kelly MP, Genant HK, Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur. N Engl J Med. 2010; 362:1761-71.
- Ciarella TE, Fyhrie DP, Parfitt AM. Effects of vertebral bone fragility and bone formation rate on the mineralization levels of cancellous bone from white females. Bone 2003; 32:311-5.
- Ensrud KE, Barrett-Connor EL, Schwartz A, Randomized trial of effect of alendronate continuation versus discontinuation in women with low BMD: results from the Fracture Intervention Trial long-term extension. J Bone Miner Res 2004; 8:1259-69.
- Goh SK, Yang KY, Koh JS, Subtrochanteric insufficiency fractures in patients on alendronate therapy. J Bone Joint Surg (Br) 2007; 89:349-53.
- Kwek EBK, Goh SK, Koh JS B, An emerging pattern of subtrochanteric stress fractures: A long-term complication of alendronate therapy. Injury 2008; 39:224-31.
- Mashiba T, Hirano T, Turner CH, Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces biomechanical properties in dog rib. J Bone Miner Res 2000; 15:613-20.
- Odvina CV, Levy S, Rao S, Zerwekh JE, Sudhaker Rao D. Unusual mid-shaft fractures during long term bisphosphonate therapy. Clin Endocrinol 2010; 72:161-8.
- Schilcher J, Aspenberg P. Incidence of steress fractures of the femoral shaft in women treated with bisphosphonate. Acta Orthop 2009; 80(4):413-5.
Acta Orthopaedica
Volume 82, 2011 - Issue 1